Surgical or medical therapy for patients with obesity and T2DM?

被引：0
|
作者：
Sten Madsbad
Jens J. Holst
机构：
[1] Hvidovre Hospital,Department of Endocrinology
[2] Novo Nordisk Foundation Center for Basic Metabolic Research,undefined
[3] Faculty of Health Sciences,undefined
[4] University of Copenhagen,undefined
来源：
Nature Reviews Endocrinology | 2016年 / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recently, 45 international medical and scientific organizations agreed that bariatric or metabolic surgery should be included among the therapeutic interventions for people with type 2 diabetes mellitus and obesity. The endorsement of these guidelines follows findings that several surgical procedures developed for weight loss improve glycaemia more effectively than any pharmacological or lifestyle approach.
引用
收藏
页码：500 / 502
页数：2
相关论文
共 50 条
  • [21] Characteristics of Remission Patients with Newly Diagnosed T2DM in Intensive Therapy
    Wan, Xuesi
    Chen, Ailing
    Deng, Wanping
    Liu, Liehua
    Li, Hai
    Liu, Jianbin
    Fang, Donghong
    Guan, Hongyu
    Liang, Minhua
    Li, Yanbing
    DIABETES, 2011, 60 : A264 - A264
  • [22] THERAPY Risk of metformin use in patients with T2DM and advanced CKD
    Schernthaner, Guntram
    Schernthaner-Reiter, Marie Helene
    NATURE REVIEWS ENDOCRINOLOGY, 2015, 11 (12) : 697 - 698
  • [23] Oxidative stress parameters and keap 1 variants in T2DM: Association with T2DM, diabetic neuropathy, diabetic retinopathy, and obesity
    Khalili, Farnaz
    Vaisi-Raygani, Asad
    Shakiba, Ebrahim
    Kohsari, Maryam
    Dehbani, Maryam
    Naseri, Rozita
    Asadi, Soheila
    Rahimi, Ziba
    Rahimi, Mehrali
    Rahimi, Zohreh
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (01)
  • [24] OBESITY, T2DM, METABOLIC SYNDROME INFLUENCE MORTALITY IN NAFLD IN A COHORT OF MEXICAN PATIENTS
    Perez-Arredondo, L. A.
    Cordero-Perez, P.
    Alarcon-Galvan, G.
    Martinez-Macias, R. F.
    Silvera-Linares, A.
    Munoz-Espinosa, L. E.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S736 - S736
  • [25] PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
    Gross, Barbara
    Pawlak, Michal
    Lefebvre, Philippe
    Staels, Bart
    NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (01) : 36 - 49
  • [26] Association of Zinc Intake with Obesity in Japanese Patients with Type 2 Diabetes Mellitus (T2DM)
    Nedachi, Rina
    Fujihara, Kazuya
    Hatta, Mariko
    Matsubayashi, Yasuhiro
    Takeda, Yasunaga
    Ishii, Dai
    Horikawa, Chika
    Kato, Noriko
    Maegawa, Hiroshi
    Sone, Hirohito
    DIABETES, 2019, 68
  • [27] Emerging combinatorial hormone therapies for the treatment of obesity and T2DM
    Sharon A. Sadry
    Daniel J. Drucker
    Nature Reviews Endocrinology, 2013, 9 : 425 - 433
  • [28] PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
    Barbara Gross
    Michal Pawlak
    Philippe Lefebvre
    Bart Staels
    Nature Reviews Endocrinology, 2017, 13 : 36 - 49
  • [29] Systemic antibacterial use increases risks of T2DM and obesity
    Reactions Weekly, 2022, 1935 (1) : 11 - 11
  • [30] Emerging combinatorial hormone therapies for the treatment of obesity and T2DM
    Sadry, Sharon A.
    Drucker, Daniel J.
    NATURE REVIEWS ENDOCRINOLOGY, 2013, 9 (07) : 425 - 433
12345